Biogen Inc
Symbol: 0R1B.L
LSE
220.98
USDDzisiejsza cena rynkowa
27.5773
Wskaźnik P/E
0.4723
Wskaźnik PEG
32.12B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Biogen Inc (0R1B-L) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1049.9 | 4892.8 | 3802.5 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 1473.5 | 1541.1 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 2100 | 2136.4 | 1961.7 | ||||||||||||
balance-sheet.row.inventory | 0 | 2527.4 | 1344.4 | 1351.5 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 1182 | 1417.6 | 740.8 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 6859.3 | 9791.2 | 7856.5 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3729.7 | 3702.5 | 3791.8 | ||||||||||||
balance-sheet.row.goodwill | 0 | 6219.2 | 5749 | 5761.1 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 1850.1 | 2221.3 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 6219.2 | 7599.1 | 7982.4 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 460.7 | 1957.1 | 2602.2 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 928.6 | 1226.4 | 1415.1 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 8647.3 | 277.8 | 229.3 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 19985.5 | 14762.9 | 16020.8 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 26844.8 | 24554.1 | 23877.3 | ||||||||||||
balance-sheet.row.account-payables | 0 | 403.3 | 491.5 | 589.2 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 240.3 | 97.2 | 1088.2 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 257.4 | 259.9 | 174.7 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 6788.2 | 6281 | 6274 | ||||||||||||
Deferred Revenue Non Current | 0 | 400 | 333 | 330.4 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 2533.3 | 2424.2 | 2446.1 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8611.1 | 7892.9 | 8619.4 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 400 | 333 | 330.4 | ||||||||||||
balance-sheet.row.total-liab | 0 | 12045.4 | 11165.7 | 12917.6 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 17627.6 | 16466.5 | 13911.7 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -153.7 | -164.9 | -106.7 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -2674.6 | -2903.8 | -2908.9 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 14799.4 | 13397.9 | 10896.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 26844.8 | 24554.1 | 23877.3 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | -9.5 | 63.5 | ||||||||||||
balance-sheet.row.total-equity | 0 | 14799.4 | 13388.4 | 10959.7 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 460.7 | 3430.6 | 4143.3 | ||||||||||||
balance-sheet.row.total-debt | 0 | 7428.5 | 6711.2 | 7692.6 | ||||||||||||
balance-sheet.row.net-debt | 0 | 6378.6 | 3291.9 | 5431.2 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1161.1 | 3046.9 | 1556.1 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 494.8 | 518.7 | 487.3 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -305.8 | -168.6 | -426.8 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | -1063.8 | 264.3 | 250.8 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -648.7 | -890.3 | -145.5 | ||||||||||||
cash-flows.row.account-receivables | 0 | 56.7 | -222.4 | 326 | ||||||||||||
cash-flows.row.inventory | 0 | -130.9 | -320.2 | -462.4 | ||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -574.5 | -347.7 | -9.1 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 1909.6 | -1386.7 | 1918 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7237.5 | -243.2 | -294.9 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 12.3 | 595 | 28.1 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | -5140.7 | -3448.5 | -3808.7 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 8288.5 | 4661.3 | 3498.9 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | -11.3 | 24.4 | 12.9 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4088.7 | 1589 | -563.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | -187.3 | -1002.2 | -170 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | -44.3 | -1.9 | -0.7 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -750 | -1800 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | -6 | -5.6 | -115.5 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 137 | -1759.7 | -2086.2 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 35.1 | -55.7 | -59.8 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -2369.4 | 1157.9 | 930.2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1049.9 | 3419.3 | 2261.4 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 3419.3 | 2261.4 | 1331.2 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 1547.2 | 1384.3 | 3639.9 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -7237.5 | -243.2 | -294.9 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | -5690.3 | 1141.1 | 3345 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 9417 | 9433.4 | 10402.4 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3028.2 | 2797 | 2597 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 6388.8 | 6636.4 | 7805.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 4757.5 | 4362.3 | 4940.2 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 7785.7 | 7159.3 | 7537.2 | ||||||||||||
income-statement-row.row.interest-income | 0 | 276.5 | 89.3 | 11 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 268.6 | 263.7 | 289.9 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -334.5 | 1317.7 | -1120 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -334.5 | 1317.7 | -1120 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 268.6 | 263.7 | 289.9 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 494.8 | 518.7 | 487.3 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 1631.3 | 2274.1 | 2865.2 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 1296.8 | 3591.8 | 1745.2 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 135.3 | 632.8 | 52.5 | ||||||||||||
income-statement-row.row.net-income | 0 | 1161.1 | 3046.9 | 1556.1 |
Często zadawane pytania
Ile wynosi Biogen Inc (0R1B.L) aktywów ogółem?
Biogen Inc (0R1B.L) całkowite aktywa to 26844800000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.678.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -39.271.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.123.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.173.
Co to jest Biogen Inc (0R1B.L) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 1161100000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 7428500000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 4757500000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.